Burkitt lymphomas are a paradigm of MYC dysregulation, overexpressing MYC due to chromosomal translocation placing the gene under transcriptional control of the immunoglobulin heavy chain enhancer [3,4]. This evidence concerns the gene MYC and Burkitt lymphoma.